Author:
Diallo Mamadou Alpha,Yade Mamadou Samb,Ndiaye Yaye Die,Diallo Ibrahima,Diongue Khadim,Sy Saidou Abdoul,Sy Mouhamad,Seck Mame Cheikh,Ndiaye Mouhamadou,Dieye Baba,Gomis Jules François,Sow Djiby,Dème Awa Bineta,Badiane Aida Sadikh,Ndiaye Daouda
Abstract
AbstractIn 2006, Senegal adopted artemisinin-based combination therapy (ACT) as first-line treatment in the management of uncomplicated malaria. This study aimed to update the status of antimalarial efficacy more than ten years after their first introduction. This was a randomized, three-arm, open-label study to evaluate the efficacy and safety of artemether-lumefantrine (AL), artesunate-amodiaquine (ASAQ) and dihydroartemisinin-piperaquine (DP) in Senegal. Malaria suspected patients were screened, enrolled, treated, and followed for 28 days for AL and ASAQ arms or 42 days for DP arm. Clinical and parasitological responses were assessed following antimalarial treatment. Genotyping (msp1, msp2 and 24 SNP-based barcode) were done to differentiate recrudescence from re-infection; in case of PCR-confirmed treatment failure, Pfk13 propeller and Pfcoronin genes were sequenced. Data was entered and analyzed using the WHO Excel-based application. A total of 496 patients were enrolled. In Diourbel, PCR non-corrected/corrected adequate clinical and parasitological responses (ACPR) was 100.0% in both the AL and ASAQ arms. In Kedougou, PCR corrected ACPR values were 98.8%, 100% and 97.6% in AL, ASAQ and DP arms respectively. No Pfk13 or Pfcoronin mutations associated with artemisinin resistance were found. This study showed that AL, ASAQ and DP remain efficacious and well-tolerated in the treatment of uncomplicated P. falciparum malaria in Senegal.
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Trape, J. et al. The rise and fall of malaria in a west African rural community, Dielmo, Senegal, from 1990 to 2012: a 22 year longitudinal study. Lancet Infect. Dis. 14, 476–488 (2014).
2. Sinclair, D., Zani, B., Donegan, S., Olliaro, P. & Garner, P. Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database Syst. Rev. https://doi.org/10.1002/14651858.CD007483.pub2 (2009).
3. USAID. Evaluation of the Impact of the Scale-up of Malaria Control Interventions on All- Cause Mortality in Children under Five Years of Age in Senegal. USAID (2015).
4. Kone, G. K., Audibert, M., Lalou, R., Lafarge, H. & Le Hersan, J.-Y. Subsidized antimalarial drugs in Dakar (Senegal): Do the poor benefit? Etudes Doc. 1–25 (2017).
5. Thiam, S. et al. Scale-up of home-based management of malaria based on rapid diagnostic tests and artemisinin-based combination therapy in a resource-poor country: results in Senegal. Malar. J. 11, 334 (2012).